Aura Biosciences
Richard Akrong, MBA, CFE, CISA, has a diverse work experience in various accounting and consulting roles. Richard is currently working at Aura Biosciences as the Senior Manager of Accounting. Prior to this, they held the position of Accounting Manager at Aura Biosciences. Before joining Aura Biosciences, Richard worked as an Associate Manager of Internal Audit at Biogen from April 2020 to August 2021. Richard also worked at EY as a Senior in Advisory Risk from June 2018 to April 2020. Richard's experience includes working as a Management Consultant at RGP from January 2017 to June 2018. Richard also served as a Senior Accountant in Financial Reporting at Mohawk Industries from 2015 to 2017. Additionally, they held positions as a Staff Accountant at Biostage, Inc. from August 2014 to December 2015, and as an Accountant at Cognex Corporation from 2013 to 2014. Richard began their career as an Accounting Specialist at Imperial Distributors from 2009 to 2013. Overall, Richard Akrong has a strong background in accounting and has worked in a variety of industries, including biotechnology and manufacturing.
Richard Akrong holds a Master of Business Administration (MBA) degree in Executive Management from Ohio University. Richard also obtained a Bachelor of Science (BSc) degree in Business Administration with a specialization in Accounting from Assumption University. In addition, Richard has completed a certification as a Certified Information Systems Auditor (CISA) from ISACA in December 2019. Richard has also attained the Certified Fraud Examiner (CFE) certification from the Association of Certified Fraud Examiners (ACFE). The specific month and year of obtaining the CFE certification are not provided.
Aura Biosciences
1 followers
Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach they call molecular surgery.